Aug 23, 2022 / 06:00AM GMT
Kari Krogstad - Medistim ASA - President & CEO
Yes. Very good morning, everyone, and welcome to Medistim's second-quarter and first-half 2022 results presentation. My name is Kari Krogstad. I'm the CEO at the company. And together with CFO Thomas Jakobsen, we are going to take you through the quarterly and first-half results.
And we will go through the highlights, and then Thomas will take us through the financial statements. And we will get back to commenting on the business segments update and the implementing -- the strategy.
So highlights for the second quarter. As we can see, our revenues -- ends this quarter at NOK117.5 million. And this means that we are delivering another all-time high for quarterly sales. So we're very pleased about that. This is actually the sixth quarter in a row above NOK100 million in sales revenues.
And we are particularly happy with seeing that our efforts in the strategic target areas of converting the flow market to an imaging and flow market is really paying off. And we are seeing a greater development here, with 65.4% growth in sales in
Q2 2022 Medistim ASA Earnings Call Transcript
Mar 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers